期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effect of combining different calcium concentration dialysate on calcium balance in peritoneal dialysis patients
1
作者 ZHAO Hui-ping WU Bei LU Li-xia QIAO Jie WU Xiang-lan WANG Mei 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第22期4009-4013,共5页
Background Calcium and phosphorus metabolic disturbance are common in dialysis patients and associated with increased morbidity and mortality. Therefore, maintaining the balance of calcium and phosphate metabolism and... Background Calcium and phosphorus metabolic disturbance are common in dialysis patients and associated with increased morbidity and mortality. Therefore, maintaining the balance of calcium and phosphate metabolism and suitable intact parathyroid hormone (iPTH) level has become the focus of attention. We investigated the effects of different peritoneal dialysate calcium concentrations on calcium phosphate metabolism and iPTH in continuous ambulatory peritoneal dialysis (CAPD) patients. Methods Forty stable CAPD patients with normal serum calcium were followed for six months of treatment with 1.25 mmol/L calcium dialysate (DCa1.25, PD4, 22 patients) or a combination of 1.75 mmol/L calcium dialysate (DCa1.75, PD2) and PD4 (18 patients) twice a day respectively. Total serum calcium (after albumin correction), serum phosphorus, iPTH, alkaline phosphatase (ALP) and blood pressure were recorded before and 1, 3 and 6 months after treatment commenced. Results No significant difference was found in baseline serum calcium, phosphorus between the two patient groups, but the levels of iPTH were significantly different. No significant changes were found in the dosage of calcium carbonate and active vitamin D during 6 months. In the PD4 group, serum calcium level at the 1st, 3rd, 6th months were significantly lower than the baseline (P 〈0.05). There was no significant difference in serum phosphorus after 6 months treatment. iPTH was significantly higher (P 〈0.001) at the 1st, 3rd, and 6th months compared with the baseline. No differences were seen in ALP and blood pressure. In the PD4+PD2 group, no significant changes in serum calcium, phosphorus, iPTH, ALP and BP during the 6-month follow-up period. Conclusions Treatment with 1.25 mmol/L calcium dialysate for six months can decrease serum calcium, increase iPTH, without change in serum phosphorus, ALP, and BP. The combining of PD4 and PD2 can stabilize the serum calcium and avoid fluctuations in iPTH levels. 展开更多
关键词 peritoneal dialysis calcium phosphate metabolism dialysate calcium concentration parathyroid hormone
原文传递
FGF23 associated bone diseases
2
作者 Eryuan Liao 《Frontiers of Medicine》 SCIE CSCD 2013年第1期65-80,共16页
Recently,fibroblast growth factor 23(FGF23)has sparked widespread interest because of its potential role in regulating phosphate and vitamin D metabolism.In this review,we summarized the FGF superfamily,the mechanism ... Recently,fibroblast growth factor 23(FGF23)has sparked widespread interest because of its potential role in regulating phosphate and vitamin D metabolism.In this review,we summarized the FGF superfamily,the mechanism of FGF23 on phosphate and vitamin D metabolism,and the FGF23 related bone disease. 展开更多
关键词 fibroblast growth factor 23 FGF receptor phosphate metabolism KLOTHO bone disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部